J Korean Child Neurol Soc.  1999 Dec;7(2):244-249.

GM2 Gangliosidosis II

Affiliations
  • 1Department of Pediatrics, Yonsei University, College of Medicine, Korea.
  • 2The Institute of Handicapped Children, Korea.
  • 3Department of Pediatrics, Ajou University School of Medicine, Korea.
  • 4Laboratory of Biochemical and Molecular Medicine, Korea.

Abstract

GM2 gangliosidosis II(Sandhoff disease) is a lysosomal storage disease due to deficiency of beta-hexosaminidase activity, transmitted by mode of autosomal recessive. Clinical features are so variable, ranging from infantile onset resulting death before 4 years, to subacute or chronic forms with more slowly progressive neurologic condition. We experienced a case of GM2 gangliosidosis II in a 14 months old male who had developmental deterioration and seizures, so we report and review the related literatures.

Keyword

GM2 gangliosidosis II; Lysosomal storage disease; Hexosaminidase

MeSH Terms

beta-N-Acetylhexosaminidases
Gangliosidoses, GM2*
Hexosaminidases
Humans
Infant
Lysosomal Storage Diseases
Male
Seizures
Hexosaminidases
beta-N-Acetylhexosaminidases
Full Text Links
  • JKCNS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr